NFKB1 and neoplasm: Among the breast cancers, the breast cancer cells recruit MDSC using cytokines and chemokines via three pathways, STAT3/IRF-8, PTEN/Akt and STAT3-NF-κB-IDO, to suppress anti-tumor immune responses and facilitate cancer cell proliferation (144).